Compile Data Set for Download or QSAR
Found 3 Enz. Inhib. hit(s) with Target = 'Activin receptor type-1' and Ligand = 'BDBM161920'
TargetActivin receptor type-1(Homo sapiens (Human))
The Brigham and Women's Hospital, Inc.; Dept. of Health and Human Services, National Institutes of Health

US Patent
LigandPNGBDBM161920(US10017516, Compound 53 | US9682983, 52 | US968298...)copy SMILEScopy InChI
Affinity DataIC50: 8nMpH: 7.5Assay Description:Specifically, compounds were assayed using LANCE® Ultra ULight¿ technology (Perkin Elmer) against human ALK1-6 enzymes (ALK1: Life Technologies, ALK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28S4N3RUS Patent
TargetActivin receptor type-1(Homo sapiens (Human))
The Brigham and Women's Hospital, Inc.; Dept. of Health and Human Services, National Institutes of Health

US Patent
LigandPNGBDBM161920(US10017516, Compound 53 | US9682983, 52 | US968298...)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Compounds were assessed in ALK1-6 enzymatic assays. Specifically, compounds were assayed using LANCE® Ultra ULight technology (Perkin Elmer) against ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q20P12CNUS Patent
TargetActivin receptor type-1(Homo sapiens (Human))
The Brigham and Women's Hospital, Inc.; Dept. of Health and Human Services, National Institutes of Health

US Patent
LigandPNGBDBM161920(US10017516, Compound 53 | US9682983, 52 | US968298...)copy SMILEScopy InChI
Affinity DataIC50: 8.60nMpH: 7.5Assay Description:Specifically, compounds were assayed using LANCE® Ultra ULight¿ technology (Perkin Elmer) against human ALK1-6 enzymes (ALK1: Life Technologies, ALK2...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q28S4N3RUS Patent